BofA Securities Downgrades 10X Genomics (TXG) to Underperform
Tweet Send to a Friend
BofA Securities analyst Derik de Bruin downgraded 10X Genomics (NASDAQ: TXG) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
